Strategic Advocates’s Axon Enterprise AXON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.9K Sell
68
-1,836
-96% -$954K 0.13% 109
2025
Q4
$1.09M Buy
1,904
+48
+3% +$29.8K 0.28% 49
2025
Q3
$1.33M Buy
1,856
+22
+1% +$16.7K 0.35% 45
2025
Q2
$1.52M Sell
1,834
-58
-3% -$39.5K 0.45% 38
2025
Q1
$995K Buy
+1,892
New +$1.11M 0.35% 47
2024
Q1
Sell
-5,757
Closed -$1.49M 131
2023
Q4
$1.49M Sell
5,757
-1,085
-16% -$245K 0.63% 36
2023
Q3
$1.36M Buy
+6,842
New +$1.35M 0.64% 32

Other funds holding AXON

Strategic Advocates's AXON Position: Q1 2026 in Review

Strategic Advocates reduced its Axon Enterprise (AXON) stake by 96% in Q1 2026, selling an estimated $954K and leaving 68 shares worth $28.9K. The position accounts for 0.13% of the portfolio, ranked #109.

Strategic Advocates first reported a position in AXON in Q3 2023 and has held it in 7 quarters since. The position peaked at $1.52M in Q2 2025. 1,048 funds tracked by Wall St. Rank hold AXON as of Q1 2026.

  • Strategic Advocates held 68 shares of Axon Enterprise worth $28.9K as of Q1 2026.
  • Strategic Advocates sold 1,836 Axon Enterprise shares in Q1 2026, an estimated $954K.
  • Axon Enterprise made up 0.13% of Strategic Advocates's portfolio in Q1 2026, its #109 holding.
  • Strategic Advocates first reported a position in Axon Enterprise in Q3 2023 and has held it in 7 quarters since.
  • Strategic Advocates's Axon Enterprise position peaked at $1.52M in Q2 2025.
  • 1,048 funds tracked by Wall St. Rank held Axon Enterprise as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.